Syntezza Bioscience
Molecular Biology Products and Services
Startup Mature Health Tech & Life Sciences Est. 2004
Total Raised
Undisclosed
Mature
Last Round
Undisclosed
Team
2
11-50 employees
Confidence
90/100
About
Syntezza Bioscience is a provider and exclusive distributor of molecular biology products and services. Its products include custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents, and are designated for NGS and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) screens. The company offers both Sanger and NGS sequencing services. Syntezza Bioscience also leads contract research projects in the diagnostics field.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsMolecules
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
molecular-biologytestinggenetic-engineeringchemicalslaboratories
Details
Product Stage
Released
Employees
11-50
Exact Count
16
District
Jerusalem District
Founded
2004
Registrar
513457283
Crunchbase
syntezza-bioscience
Locations
Hartom Street 17, Jerusalem, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Aug 31, 2024
Verified by
Sharon Shapira
Missing
funding rounds, news, markets, not claimed
Team (2)
Rafi Gassel
VP
Aryeh Gassel
Director
Internal
Created by
Rachel Wain (rachelwain18@gmail.com)
Created
2014-11-10T00:00:00.000Z
Last editor
Natasha Voloshin (natashavolo@gmail.com)